Stock research
ACHV Achieve Life Sciences, Inc.
Healthcare • Biotechnology
Achieve Life Sciences, Inc. operates as a clinical-stage pharmaceutical firm, concentrating on the development and market introduction of cytisinicline. This compound is aimed at assisting with smoking cessation and...…
Achieve Life Sciences, Inc. operates as a clinical-stage pharmaceutical firm, concentrating on the development and market introduction of cytisinicline. This compound is aimed at assisting with smoking cessation and nicotine dependence, with commercial activities spanning Canada, the United States, and the United Kingdom. Cytisinicline is a naturally occurring alkaloid, which functions by engaging with nicotine receptors in the brain to lessen the intensity of nicotine withdrawal symptoms. The company holds licensing agreements with Sopharma AD and the University of Bristol. Its corporate headquarters are located in Vancouver, Canada.
5Y change
-11.57%
Range high
$9.93
Congress · 90d
0
Insiders · 90d
0
Public signal layer
Who is disclosing activity in ACHV?
Price
Showing 5Y history. Source: FMP historical price full.
- Prev Close
- $6.30
- Day High
- $6.46
- Day Low
- $6.05
- 52w High
- $7.11
- 52w Low
- $2.37
- Volume
- 1,173,314
- Avg Volume
- Beta
- 2.217
* TTM/most recent where available
Company
- Ticker
- ACHV
- Exchange
- Sector
- Healthcare
- Industry
- Biotechnology
- Country
- US
- CEO
- Andrew D. Goldberg
- Employees
- 28
- Website
- www.achievelifesciences.com
Key Metrics
- Market Cap
- 659M
- P/E
- P/B
- P/S
- EV/EBITDA
- ROE
- Net Margin
- Div Yield
- FCF/Share
* TTM/most recent where available
DCF Valuation
Standard DCF
Levered DCF
Market Price
DCF vs Price (30D window)
Price uses last 30 days; DCF line holds latest value across the window.DCF line = solid green (latest value repeated across window), Price = dashed blue (daily closes).